Ivor Royston - 25 Nov 2021 Form 4 Insider Report for Viracta Therapeutics, Inc. (VIRX)

Role: CEO & President, Director
Signature: /s/ Michael Mueller, as Attorney-in-Fact
Issuer symbol: VIRX
Transactions as of: 25 Nov 2021
Net transactions value: -$133,495
Form type: 4
Filing time: 29 Nov 2021, 18:46:46 UTC
Previous filing: 15 Nov 2021
Next filing: 30 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIRX	Common Stock	Options Exercise	$0	+50,437	+9.2%	$0.000000	599,036	25 Nov 2021	Direct	F1
transaction	VIRX	Common Stock	Sale	$57,194	-11,914	-2%	$4.80	587,122	26 Nov 2021	Direct	F2, F3
transaction	VIRX	Common Stock	Sale	$76,301	-15,833	-2.7%	$4.82	571,289	29 Nov 2021	Direct	F2, F4
holding	VIRX	Common Stock						18,599	25 Nov 2021	By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIRX	Restricted Stock Units	Options Exercise	$0	-50,437	-12%	$0.000000	353,066	25 Nov 2021	Common Stock	50,437		Direct	F1, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Viracta Therapeutics, Inc. Common Stock.
F2	The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the reporting person's award agreement to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction.
F3	Represents the weighted average share price of an aggregate total of 11,914 shares sold in the price range of $4.7150 to $5.01 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4	Represents the weighted average share price of an aggregate total of 15,833 shares sold in the price range of $4.62 to $5.34 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5	One-eighth (1/8th ) of the RSU Award will vest on November 25, 2021 (the "First Vesting Date"), and one-sixteenth (1/16th ) of the RSU Award will vest each Quarterly Vesting Date (as defined below) after the First Vesting Date, in each case subject to the reporting person continuing to be a Service Provider (as defined in the Viracta Subsidiary, Inc. 2016 Equity Incentive Plan, the "Plan") through the applicable vesting date. For the purposes of the foregoing, "Quarterly Vesting Date" means February 25, May 25, August 25,and November 25 of each year.